Treatment News : Hormone-Based Birth Control Raises HIV Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » July 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 21, 2011

Hormone-Based Birth Control Raises HIV Risk

A new study shows that HIV-positive women are twice as likely to transmit the virus to a sexual partner if they use hormone-based birth control, The New York Times reports.

Similarly, researchers from the University of Washington found that HIV-negative women raised their chances of getting the virus if they were on the pill or taking a hormone shot like Depo-Provera.

As reported at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Rome, the results indicate a need for follow-up studies, and researchers cautioned women to not immediately change their birth control practices.

The study was conducted from 2004 to 2010 in Kenya, Uganda, Rwanda, Botswana, Zambia, Tanzania and South Africa. Nearly 2,500 HIV-positive women with HIV-negative partners participated in the study. One third of the women took hormonal contraception. The partners of those women had a 2.61 percent chance of getting HIV within one year.

Within the same region and time period, researchers looked at 1,300 couples in which the men were HIV positive and their female partners were not. In this group, 20 percent of the women were on a hormone-based birth control, mostly injections, and they had a 6.6 percent chance of seroconverting within a year’s time.

To read the Times article, click here.

Search: Rome, Italy, University of Washington, International AIDS Society, IAS Conference on HIV, Kenya, Uganda, Rwanda, Botswana, Zambia, Tanzania, South Africa, Depo Provera, birth control


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


  comments 1 - 1 (of 1 total)    

Luisa Charnaud Cruz, Guatemala, 2011-07-29 10:43:39
I would like to know more about study and know what is the fisiolophatologist mecanism

comments 1 - 1 (of 1 total)    


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.